Aurora Cannabis ROA 2017-2020 | ACB

Current and historical return on assets (ROA) values for Aurora Cannabis (ACB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Aurora Cannabis ROA for the three months ending March 31, 2020 was -6.91%.
Aurora Cannabis ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $-1.07B $3.52B -27.60%
2019-12-31 $-1.08B $3.54B -26.90%
2019-09-30 $-0.29B $4.25B -7.13%
2019-06-30 $-0.22B $4.16B -5.54%
2019-03-31 $-0.16B $4.18B -4.71%
2018-12-31 $-0.05B $3.69B -1.98%
2018-09-30 $0.14B $3.79B 7.50%
2018-06-30 $0.06B $1.51B 6.19%
2018-03-31 $-0.01B $1.32B -1.65%
2017-12-31 $0.01B $0.58B 1.82%
2017-09-30 $-0.00B $0.28B -2.30%
2017-06-30 $-0.01B $0.24B -16.46%
2017-03-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.428B $0.215B
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.899B 29.12
Medtronic (MDT) Ireland $132.114B 21.48
Stryker (SYK) United States $73.365B 23.81
Boston Scientific (BSX) United States $53.161B 24.99
Baxter (BAX) United States $45.654B 0.00
Lonza Group Ag (LZAGY) Switzerland $36.676B 0.00
Terumo (TRUMY) Japan $29.978B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.400B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.077B 16.41
ResMed (RMD) United States $23.266B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $17.849B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.566B 66.31
Insulet (PODD) United States $11.896B 1178.56
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Perrigo (PRGO) Ireland $7.466B 13.36
Quidel (QDEL) United States $7.350B 57.76
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Hill-Rom Holdings (HRC) United States $6.767B 19.08
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 0.00
Canopy Growth (CGC) Canada $6.093B 0.00
Haemonetics (HAE) United States $5.517B 33.14
ICU Medical (ICUI) United States $4.159B 30.34
GW Pharmaceuticals (GWPH) United Kingdom $3.796B 0.00
Neogen (NEOG) United States $3.754B 63.59
Agios Pharmaceuticals (AGIO) United States $3.564B 0.00
Envista Holdings (NVST) United States $3.366B 0.00
NuVasive (NUVA) United States $3.106B 24.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.909B 0.00
National Vision Holdings (EYE) United States $2.150B 37.19
TG Therapeutics (TGTX) United States $2.055B 0.00
AtriCure (ATRC) United States $1.916B 0.00
Cardiovascular Systems (CSII) United States $1.366B 0.00
NanoString Technologies (NSTG) United States $1.152B 0.00
Aphria (APHA) Canada $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.060B 21.13
Cerus (CERS) United States $1.020B 0.00
MacroGenics (MGNX) United States $0.945B 0.00
InMode (INMD) Israel $0.937B 19.80
OraSure Technologies (OSUR) United States $0.902B 181.75
PetIQ (PETQ) United States $0.871B 25.15
Omeros (OMER) United States $0.811B 0.00
Quanterix (QTRX) United States $0.781B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.735B 0.00
VAREX IMAGING (VREX) United States $0.734B 18.21
Eagle Pharmaceuticals (EGRX) United States $0.702B 50.26
Meridian Bioscience (VIVO) United States $0.662B 24.93
Zynex (ZYXI) United States $0.644B 64.67
Vapotherm (VAPO) United States $0.567B 0.00
Lantheus Holdings (LNTH) United States $0.546B 10.98
LeMaitre Vascular (LMAT) United States $0.543B 30.91
Surmodics (SRDX) United States $0.503B 60.62
Owens & Minor (OMI) United States $0.500B 13.22
Repro-Med Systems (KRMD) United States $0.402B 337.33
Cytosorbents (CTSO) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.362B 26.32
BioLife Solutions (BLFS) United States $0.336B 149.54
Viemed Healthcare (VMD) United States $0.321B 28.72
Organigram Holdings (OGI) Canada $0.306B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.283B 0.00
HEXO (HEXO) $0.258B 0.00
Female Health (VERU) United States $0.247B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Chembio Diagnostics (CEMI) United States $0.169B 0.00
Evolus (EOLS) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 13.66
Bovie Medical (APYX) United States $0.152B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.145B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.127B 0.00
MTech Acquisition (KERN) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.109B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
United-Guardian (UG) United States $0.072B 16.77
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00